Share purchases in key companies are always interesting but we wouldn’t normally mention anyone buying a relatively small amount of shares, especially not an amount adding out to ‘only’ £75,000.
Image: Dr Martens
But given that the company concerned saw fit to announce the purchase itself and given that the company is in the middle of a major turnaround, it’s of more interest than it might usually be.
Dr Martens announced on Monday that Robert Hanson, who joined the board as an independent non-executive director in March, has purchased 96,000 shares in Dr Martens – worth over £75,000.
Share purchases by insiders are particularly significant given that those insiders tend to have the best view of how the company is faring with its turnaround and an individual committing a significant sum of their own money is particularly interesting.
Hanson currently serves as CEO of The Duckhorn Portfolio. His previous roles include EVP and president of Constellation Brands’ Wine & Spirits, president of Americas at Levi’s as well as CEO roles at American Eagle Outfitters and John Hardy.
He purchased 96,000 ordinary shares at a price of £0.7886 per share. The buy suggests he believes that the shares, which are much lower than their all-time high of £5+, represent good value and should rise.
Dr Martens is currently working through a recovery from a major period of weakness and it seems to be yielding results. Its first half update in November showed progress, with America recovering in particular even though EMEA still showed weakness.
A week later, it also announced the opening of its new Soho, London flagship and that’s a key development. The store “represents the most elevated expression of the… brand to date”. The first-ever ‘beacon’ store is on Brewer Street with its two floors spanning 3,400 sq ft to make it the brand’s biggest UK flagship – “built to bring the people and product of Dr Martens together”.
